IGM Biosciences Balance Sheet Health
Financial Health criteria checks 6/6
IGM Biosciences has a total shareholder equity of $78.9M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $304.5M and $225.6M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$218.79m |
| Equity | US$78.95m |
| Total liabilities | US$225.56m |
| Total assets | US$304.51m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 1K0's short term assets ($229.6M) exceed its short term liabilities ($44.0M).
Long Term Liabilities: 1K0's short term assets ($229.6M) exceed its long term liabilities ($181.6M).
Debt to Equity History and Analysis
Debt Level: 1K0 is debt free.
Reducing Debt: 1K0 had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 1K0 has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: 1K0 has sufficient cash runway for 1.5 years if free cash flow continues to reduce at historical rates of 27.2% each year.